Why the study?
Does multimodality therapy improve clinical outcomes in patients with angiosarcoma of the scalp and face?
Population
Patients with angiosarcoma of the scalp and face
Design
Cohort
Authors
Loading...
May support multimodality therapy in younger patients with resectable scalp/face angiosarcoma; leaves open prospective validation.
Does multimodality therapy improve clinical outcomes in patients with angiosarcoma of the scalp and face?
Multimodality therapy is associated with improved survival and locoregional control in angiosarcoma of the scalp and face, particularly in younger patients with resectable disease.
Patel et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: